3B Blackbio [3BBLACKBIO] vs Biocon [BIOCON] Detailed Stock Comparison

3B Blackbio Diagnostics Ltd.

BSE
Loading...

Biocon Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: 3B Blackbio Diagnostics Ltd. wins in 10 metrics, Biocon Ltd. wins in 9 metrics, with 0 ties. 3B Blackbio Diagnostics Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric 3B Blackbio Diagnostics Ltd. Biocon Ltd. Better
P/E Ratio (TTM) 20.80 71.84 3B Blackbio Diagnostics Ltd.
Price-to-Book Ratio 3.89 1.68 Biocon Ltd.
Debt-to-Equity Ratio 0.09 50.02 3B Blackbio Diagnostics Ltd.
PEG Ratio 0.34 0.17 Biocon Ltd.
EV/EBITDA 20.17 19.22 Biocon Ltd.
Profit Margin (TTM) 44.56% 3.59% 3B Blackbio Diagnostics Ltd.
Operating Margin (TTM) 42.39% 7.63% 3B Blackbio Diagnostics Ltd.
EBITDA Margin (TTM) 42.39% 7.63% 3B Blackbio Diagnostics Ltd.
Return on Equity 17.60% 3.66% 3B Blackbio Diagnostics Ltd.
Return on Assets (TTM) 16.13% 1.72% 3B Blackbio Diagnostics Ltd.
Free Cash Flow (TTM) $424.53M $17.18B Biocon Ltd.
Dividend Yield N/A 0.26% N/A
1-Year Return -24.89% 27.63% Biocon Ltd.
Price-to-Sales Ratio (TTM) 9.21 3.37 Biocon Ltd.
Enterprise Value $11.32B $643.51B Biocon Ltd.
EV/Revenue Ratio 8.78 3.82 Biocon Ltd.
Gross Profit Margin (TTM) 72.47% 67.91% 3B Blackbio Diagnostics Ltd.
Revenue per Share (TTM) $152 $133 3B Blackbio Diagnostics Ltd.
Earnings per Share (Diluted) $66.57 $4.87 3B Blackbio Diagnostics Ltd.
Beta (Stock Volatility) 0.47 0.25 Biocon Ltd.

3B Blackbio Diagnostics Ltd. vs Biocon Ltd. Stock Performance Analysis

Loading Price Chart...

3BBLACKBIO
BIOCON

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
3B Blackbio Diagnostics Ltd.-0.73%-9.19%-9.77%-7.53%-11.62%-20.14%
Biocon Ltd.0.87%-2.94%15.38%9.96%7.13%7.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
3B Blackbio Diagnostics Ltd.-24.89%58.97%58.97%58.97%58.97%58.97%
Biocon Ltd.27.63%78.42%11.37%265.74%609.92%1,204.47%

Performance & Financial Health Analysis: 3B Blackbio Diagnostics Ltd. vs Biocon Ltd.

Metric3BBLACKBIOBIOCON
Market Information
Market Cap i₹11.13B₹566.52B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i12,5082,496,867
90 Day Avg. Volume i12,8603,790,310
Last Close₹1,129.75₹416.05
52 Week Range₹1,083.50 - ₹1,750.00₹327.60 - ₹440.40
% from 52W High-35.44%-5.53%
All-Time High₹2,350.00 (Dec 09, 2024)₹487.75 (Dec 21, 2020)
% from All-Time High-51.93%-14.70%
Growth Metrics
Quarterly Revenue Growth0.98%0.09%
Quarterly Earnings Growth0.62%4.73%
Financial Health
Profit Margin (TTM) i0.45%0.04%
Operating Margin (TTM) i0.42%0.08%
Return on Equity (TTM) i0.18%0.04%
Debt to Equity (MRQ) i0.0950.02
Cash & Liquidity
Book Value per Share (MRQ)₹355.75₹207.92
Cash per Share (MRQ)₹27.44₹45.84
Operating Cash Flow (TTM) i₹619.97M₹17.78B
Levered Free Cash Flow (TTM) i₹476.91M₹10.13B
Dividends
Last 12-Month Dividend Yield iN/A0.26%
Last 12-Month Dividend iN/A₹1.00

Valuation & Enterprise Metrics Analysis: 3B Blackbio Diagnostics Ltd. vs Biocon Ltd.

Metric3BBLACKBIO (Apr 24, 2026)BIOCON (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i20.8071.84
Forward P/E iN/A38.56
PEG Ratio i0.340.17
Price to Sales (TTM) i9.213.37
Price to Book (MRQ) i3.891.68
Market Capitalization
Market Capitalization i₹11.13B₹566.52B
Enterprise Value i₹11.32B₹643.51B
Enterprise Value Metrics
Enterprise to Revenue i8.783.82
Enterprise to EBITDA i20.1719.22
Risk & Other Metrics
Beta i0.470.25
Book Value per Share (MRQ) i₹355.75₹207.92

Financial Statements Comparison: 3B Blackbio Diagnostics Ltd. vs Biocon Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric3BBLACKBIO (2025)BIOCON (2025)
Revenue/Sales i964.69M150.52B
Cost of Goods Sold i256.46M51.98B
COGS % of Revenue i26.6%34.5%
Gross Profit i708.23M98.54B
Gross Margin i73.4%65.5%
Research & Development i5.12M6.34B
Operating Income (EBIT) i493.22M16.26B
Operating Margin i51.1%10.8%
EBITDA i591.08M33.60B
EBITDA Margin i61.3%22.3%
Pre-Tax Income i639.98M18.87B
Pre-Tax Income % of Revenue i66.3%12.5%
Income Tax i163.07M4.57B
Income Tax % of Revenue i16.9%3.0%
Net Income (Profit) i476.91M14.29B
Profit Margin i49.4%9.5%

Balance Sheet & Liquidity Metrics

Metric3BBLACKBIO (2025)BIOCON (2025)
Cash & Equivalents i117.07M32.27B
Total Current Assets i1.32B162.86B
Total Current Assets % of Revenue i137.0%108.2%
Total Current Liabilities i185.88M143.34B
Total Current Liabilities % of Revenue i19.3%95.2%
Long-Term Debt i3.07M129.45B
Long-Term Debt % of Revenue i0.3%86.0%
Total Shareholders Equity i2.71B277.13B
Retained Earnings i2.51B189.59B
Retained Earnings % of Revenue i259.9%126.0%
Property, Plant & Equipment i85.37M4.32B

Cash Flow Statement Comparison

Metric3BBLACKBIO (2025)BIOCON (2025)
Operating Cash Flow i619.97M17.78B
Operating Cash Flow % of Revenue i64.3%11.8%
Capital Expenditures i-9.04M-21.36B
Free Cash Flow i424.53M17.18B
FCF Margin i44.0%11.4%
Debt Repayment i-5.44M-97.70B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

Metric3BBLACKBIOBIOCON
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i8.58M1.62B
Float Shares i2.69M583.07M
% Held by Insiders i65.90%54.07%
% Held by Institutions i1.95%24.88%
% Held by Public i32.15%21.05%

Dividend Analysis & Yield Comparison: 3B Blackbio Diagnostics Ltd. vs Biocon Ltd.

Metric3BBLACKBIOBIOCON
Last 12-Month Dividend iN/A₹1.00
Last 12-Month Dividend Yield iN/A0.26%
3-Year Avg Annual Dividend iN/A₹1.33
3-Year Avg Dividend Yield iN/A0.36%
3-Year Total Dividends iN/A₹4.00
Ex-Dividend DateN/AJul 04, 2025